SENS Senseonics Holdings, Inc.

NASDAQ
$7.81

Senseonics Holdings, Inc. (SENS) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.48 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +35.6% since its last earnings release on August 6, 2026.

Senseonics Missed Consensus Estimates, Raises Guidance, but Remains In-line with Estimates
Thursday, August 6, 2026 · 4:01 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 4:00 PM ET
Earnings Whisper
-
vs ($0.48)
Rev est $15.81M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $7.52

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Senseonics Holdings, Inc.

Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology.

Sector

Healthcare

Industry

Medical Appliances/Equipment